ERIS Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 674.09 | 601.32 | 421.52 |
| Operating Expense | 353.62 | 362.32 | 283.80 |
| Net Profit | 149.57 | 99.99 | 30.47 |
| Net Profit Margin | 22.19 | 16.63 | 7.23 |
| Earning Per Share | 10.98 | 7.34 | 2.24 |
| EBIDTA | 276.28 | 209.90 | 135.52 |
| Effective Tax Rate | 12.77 | 11.37 | 6.18 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 674.09 |
| Operating Expense | 353.62 |
| Net Profit | 149.57 |
| Net Profit Margin | 22.19 |
| Earning Per Share | 10.98 |
| EBIDTA | 276.28 |
| Effective Tax Rate | 12.77 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,697.75 | 1,486.71 | 1,330.73 |
| Operating Expenses Annual | 1,211.20 | 1,032.89 | 825.61 |
| Operating Profit Annual | 522.06 | 488.65 | 522.38 |
| Interest Annual | 220.24 | 57.42 | 20.81 |
| Depreciation | 47.31 | 34.15 | 29.76 |
| Net Profit Annual | 77.39 | 299.72 | 398.01 |
| Tax Annual | 42.66 | 29.12 | 38.90 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,697.75 |
| Operating Expenses Annual | 1,211.20 |
| Operating Profit Annual | 522.06 |
| Interest Annual | 220.24 |
| Depreciation | 47.31 |
| Net Profit Annual | 77.39 |
| Tax Annual | 42.66 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 51.93 | 47.48 | 44.70 |
| Cash Flow from Operations | 701.86 | 336.29 | 322.33 |
| Cash Flow from Investing | -358.99 | -2,491.89 | -513.30 |
| Cash Flow from Financing | -310.46 | 2,160.05 | 193.75 |
| Cash Flow at the End | 84.34 | 51.93 | 47.48 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 51.93 |
| Cash Flow from Operations | 701.86 |
| Cash Flow from Investing | -358.99 |
| Cash Flow from Financing | -310.46 |
| Cash Flow at the End | 84.34 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 30.64 | 31.97 | 38.97 |
| PBIT Margin (%) | 19.97 | 25.27 | 34.15 |
| PBT Margin (%) | 19.88 | 24.83 | 32.51 |
| Net PROFIT Margin (%) | 4.54 | 19.61 | 29.69 |
| Return On Networth / Equity (%) | 3.07 | 12.63 | 19.23 |
| Return On Networth /Employed (%) | 6.83 | 9.97 | 19.94 |
| Return On Assets (%) | 1.54 | 7.65 | 17.22 |
| Total Debt / Equity (X) | 0.96 | 0.61 | 0.08 |
| Asset Turnover Ratio (%) | 0.34 | 0.39 | 0.58 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 30.64 |
| PBIT Margin (%) | 19.97 |
| PBT Margin (%) | 19.88 |
| Net PROFIT Margin (%) | 4.54 |
| Return On Networth / Equity (%) | 3.07 |
| Return On Networth /Employed (%) | 6.83 |
| Return On Assets (%) | 1.54 |
| Total Debt / Equity (X) | 0.96 |
| Asset Turnover Ratio (%) | 0.34 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 2,412.45 | 1,516.17 | 898.16 |
| Total Current Assets Annual | 627.54 | 1,876.54 | 552.08 |
| Non Current Assets Annual | 4,594.89 | 3,473.03 | 2,231.58 |
| Total Shareholders Funds Annual | 2,514.90 | 2,524.02 | 2,221.88 |
| Total Assets Annual | 5,222.43 | 5,349.57 | 2,783.66 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 2,412.45 |
| Total Current Assets Annual | 627.54 |
| Non Current Assets Annual | 4,594.89 |
| Total Shareholders Funds Annual | 2,514.90 |
| Total Assets Annual | 5,222.43 |
EPS (INR)
Expected
8.82
Reported
8.82
Surprise
0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.15%
